Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuropathy in Waldenström's Macroglobulinemia: Pathophysiology, Prognosis and Treatment

NCT07160270 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT07160270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07160270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuropathy in Waldenström's Macroglobulinemia: Pathophysiology, Prognosis and Treatment
Lead sponsor
Rigshospitalet, Denmark
Phase
Observational
Overall status
Recruiting
Start date
May 14, 2025
Completion date
December 30, 2025
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral neuropathies, waldenstrom macroglobulinaemia